EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Europe

Clinerion announces a new technology for patient identification using fully anonymized electronic patient data.

ꟷ    “Anonymized identification” is based on fully anonymized patient records, with no use of pseudo IDs. ꟷ    PCT patent filed for a new technology which uses a comb...
Continue Reading →
Europe

Ferring Pharmaceuticals: The Scottish Medicines Consortium Approves Use of NOQDIRNA® (oral lyophilisate desmopressin), the First Licensed Treatment for Nocturia due to Idiopathic Nocturnal Polyuria in Adults

The Scottish Medicines Consortium (SMC) has announced today a positive decision for the use of NOQDIRNA®. NOQDIRNA® is the only licensed treatment for the sympto...
Continue Reading →
Europe

Antidepressant use increases risk of head injuries among persons with Alzheimer’s disease

Antidepressant use is associated with an increased risk of head injuries and traumatic brain injuries among persons with Alzheimer’s disease, according to a new study...
Continue Reading →
Asia Pacific

WuXi AppTec Immunotherapy Report: Biotech Sector Will Drive Biggest Advancements in Decades on Cancer Treatments

Small nimble biotechs to introduce a ‘golden age’ of next generation therapies like CAR-T, combination therapies, innate immune system approaches, and newer check-poi...
Continue Reading →
Europe

CPhI Annual Reports – how accurate were they 5 years on?

The CPhI predictions foresaw advancement in QbD, continuous processing, and a dramatic rise in FDA warning letters Amsterdam, 27 July 2017: CPhI Worldwide, organized ...
Continue Reading →
Europe

Treatment of CIBD now easier with methotrexate in auto-injector New: metoject® PEN approved for treatment of Crohn’s disease in Europe

Wedel (26. July 2017). Medac Gesellschaft für klinische Spezialpräparate mbH has announced that methotrexate has been approved for treatment of Crohn's disease with i...
Continue Reading →
news

CMC Biologics Enters into Development and Manufacturing Agreement with Trellis BioScience

  Development of Trellis’ monoclonal antibody (mAb) using CMC Biologics’ proprietary CHEF1® Expression Platform and Multi-column Continuous Chromatography (M...
Continue Reading →
Europe

Eisai Submits Marketing Authorisation Application to the European Medicines Agency for Lenvatinib in First-Line Hepatocellular Carcinoma

Lenvatinib filing based on pivotal Phase III REFLECT study demonstrating non-inferior overall survival compared to sorafenib Simultaneous submissions to EMA and ...
Continue Reading →
Asia Pacific

China FDA, US FDA and industry leaders debate MAH pilot being adopted nationwide

STA Pharmaceutical Co., Ltd. (STA)  – a WuXi AppTec subsidiary and a leading open-access capability and technology platform for small molecule pharmaceutical developm...
Continue Reading →
news

Avantor® Opens New Life Sciences Research Center

New Innovation Center in Bridgewater, New Jersey serves as a distinct center of collaboration where Avantor can provide broad contract research capabilities covering ...
Continue Reading →
Quotient
Laboratory Intake for Graduates 28th January 2026